Cancer is among serious health problems with an uncertain and complex structure that causes fatal results. Cancer is a disease that consists of uncontrolled proliferation of cells in different organs, whose clinical appearance, treatment and approach are different from each other and that should be controlled in the early stages. The cancer burden should be estimated in order to determine priorities for cancer control. In this context, there are many studies on diagnosis and treatment methods and a rapid development is observed in this regard. The aim is to increase the survival rate of people with cancer. In order to achieve this goal effectively, early and accurate diagnosis is especially important in the treatment of cancer, as it causes fatal results. It is known that cancer is very difficult to diagnose in the early stages and accurately with traditional diagnostic methods. At this point, the artificial intelligence, a new or current approach, comes to the agenda. Developments in this area offer very important opportunities in cancer diagnosis as in many areas. Therefore, in this study, deep learning approaches which are an artificial intelligence technique in the literature for the diagnosis of cancer disease are examined, and the applications in the literature on how these approaches are used are included. Since the subject of the study is up to date, it is considered that the study will be a guide for people or institutions working in this field.
Introduction
Cancer is a major global health threat, requiring early and accurate diagnosis to improve survival rates. Traditional methods of cancer detection, like manual image analysis, histopathology, and biopsies, are effective but time-consuming and prone to human error. Deep learning, a form of artificial intelligence (AI), has revolutionized cancer detection by enabling automatic and highly accurate analysis of complex datasets, including medical images, genomic data, and patient histories.
Deep learning models, such as Convolutional Neural Networks (CNNs), are especially effective in analyzing medical images (e.g., MRI, CT scans, and X-rays) to detect signs of cancer. These models learn to identify cancerous patterns and abnormalities with remarkable precision, often outperforming human experts. Deep learning can also incorporate other data types, like genetic information and medical records, providing a more comprehensive approach to cancer classification. This holistic analysis not only aids in early detection but also enhances personalized treatment plans.
The use of deep learning in oncology leads to the development of AI tools that support clinicians in diagnosing cancer, reducing errors, and improving treatment efficiency. These tools streamline workflows and help make better, faster decisions, ultimately transforming cancer care to be more accurate and accessible.
Working Mechanism:
Deep learning models for cancer diagnosis are trained on diverse datasets, including medical images, genomic sequences, and clinical data. The process includes:
Data Collection: Gathering images (e.g., MRI, CT, histopathology) and genetic data.
Preprocessing: Preparing the data by normalizing, augmenting, and labeling it to ensure its usability for deep learning.
Model Selection: Choosing the right deep learning architecture, such as CNNs for image-based analysis and Recurrent Neural Networks (RNNs) for genomic data.
Model Training: The model learns by processing data, calculating errors, and adjusting parameters through backpropagation until accurate predictions are achieved.
Continuous Improvement: Models can be retrained with new data, ensuring they evolve with advancements in cancer research.
The outcome is faster and more accurate cancer diagnoses, which supports clinicians in making better decisions and improving patient outcomes.
Conclusion
In conclusion, deep learning has shown tremendous potential in revolutionizing cancer detection and diagnosis, offering enhanced accuracy, speed, and efficiency compared to traditional methods. Through the application of convolutional neural networks (CNNs), recurrent neural networks (RNNs), and other advanced models, deep learning systems can analyze complex medical data—such as medical imaging, genomics, and histopathology—at a level that often surpasses human expertise. The ability to automatically detect cancerous tissues, predict patient outcomes, and personalize treatment plans has opened new avenues for early detection and precision medicine.
However, despite its promise, several challenges remain. Issues related to data quality, interpretability, and the integration of deep learning models into clinical practice need further exploration. Additionally, the need for large, annotated datasets and efforts to minimize biases in AI algorithms is critical to ensuring the equitable application of these technologies in diverse patient populations.
Looking ahead, the continued collaboration between data scientists, clinicians, and researchers will be pivotal in refining deep learning models for cancer detection. As the field progresses, there is significant potential to transform cancer care by enabling faster diagnoses, more accurate prognoses, and improved outcomes for patients worldwide. Future research and technological advancements will likely address current limitations and unlock new capabilities, bringing us closer to a future where early cancer detection is widely accessible and routine.